Metraipolis › archive › dc_f10dba5aa9db
Targeting glioblastoma with HDAC inhibitors: insights into hydroxamic acid-based therapeutic strategies — Europe PMC PMID:41331688
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41331688
- DOI
- 10.1186/s40478-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T00:38:30.681Z
- SHA-256 of the archived text
f4b5e4d733cf225326dc103f41350b6ba538657c1ecf3a006ba7421b0d6ae41e- Stable URL of this page
https://metraipolis.com/documento/dc_f10dba5aa9db
How to cite
Targeting glioblastoma with HDAC inhibitors: insights into hydroxamic acid-based therapeutic strategies — Europe PMC PMID:41331688 — Europe PMC (en), https://europepmc.org/article/MED/41331688 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f10dba5aa9db (Metraipolis archive dc_f10dba5aa9db, sha256 f4b5e4d733cf225326dc103f41350b6ba538657c1ecf3a006ba7421b0d6ae41e)
BibTeX
@misc{dcf10dba5aa9db,
title = {Targeting glioblastoma with HDAC inhibitors: insights into hydroxamic acid-based therapeutic strategies — Europe PMC PMID:41331688},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41331688},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f10dba5aa9db; sha256 f4b5e4d733cf225326dc103f41350b6ba538657c1ecf3a006ba7421b0d6ae41e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41331688. Agents can read the archived copy with the MCP tool read_document.